Celestial Biolabs Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN L72200TG1997PLC028374 Incorporated 19 November 1997 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Listed - BSE: 532871 Public Limited Company pharma
Data last updated
Revenue · FY 2023
₹16.87 Lakh
▲ 14% YoY
Net loss · FY 2023
₹57.19 Lakh
Net margin -339%
EBITDA · FY 2023
-₹54.36 Lakh
EBITDA margin -322.2%
Authorised capital
₹29 Cr
Registered with MCA
Paid-up capital
₹22.59 Cr
Issued & subscribed
Open charges
₹21.1 Cr
Satisfied ₹8.9 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
1
Provident fund records

About Celestial Biolabs Limited

Data last updated:

Celestial Biolabs Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 November 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN L72200TG1997PLC028374. Its GSTIN is 36AABCC4698Q1ZV (Telangana). The company holds 2 GST registrations, of which 1 is active. Its shares are listed on BSE: 532871.

The company has an authorised share capital of ₹29 Cr and a paid-up capital of ₹22.59 Cr. It was formerly known as Celestial Labs Limited and Celestial Technologies Limited. It is led by directors including Amit Kumar Singh (Managing Director) and Rakle Mathur Nath.

Its last annual general meeting (AGM) was held on 23 May 2024, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No 82 Venkat Reddy Nagar Narapally Medchal – Malkajgiri Dist, Hyderabad, Telangana, India – 500039.

As per the financials filed for FY 2023, the company reported a revenue of ₹16.87 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net loss of ₹57.19 Lakh (net margin -339%) and EBITDA of -₹54.36 Lakh (EBITDA margin -322.2%). Revenue has declined at a compounded annual rate (CAGR) of 68% over three years and 67% over five years.

The company has about 1 employee on its provident fund (EPFO) records.

The company is associated with 2 brands: Celestial Biolabs and Celestia. As per MCA filings, the company has open charges of ₹21.1 Cr and satisfied charges of ₹8.9 Cr on record. Court records list 21 cases involving the company, including 10 filed by the company and 2 filed against it; 2 cases are pending. The company has 94 deals on record (93 market trades, 1 ipo); the latest was in July 2019. Its 10 peer companies in the Biotechnology industry (Biotechnology, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Agrata Biotech Limited with revenue of ₹17.02 Lakh.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celestialbiolabs.com.

Company Details of Celestial Biolabs Limited
CIN L72200TG1997PLC028374
Registration Number 028374
Incorporation Date 19 November 1997
ROC Hyderabad
Listing Status Listed (BSE: 532871)
Company Status Active
Date of Last AGM 23 May 2024
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Plot No 82 Venkat Reddy Nagar Narapally Medchal – Malkajgiri Dist, Hyderabad, Telangana, India – 500039
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Celestial Biolabs Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Celestial Biolabs Limited report

Financials, compliance, directors, charges, ownership and filings for Celestial Biolabs Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Celestial Biolabs Limited

The main business activity of Celestial Biolabs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Celestial Biolabs Limited FY 2023 filings available

Celestial Biolabs Limited reported revenue of ₹16.87 Lakh (up 14% YoY) for FY 2023.

Revenue · FY 2023
₹16.87 Lakh ▲ 14%
Net loss · FY 2023
₹57.19 Lakh margin -339%
EBITDA · FY 2023
-₹54.36 Lakh margin -322.2%

Compounded Annual Growth Rate (CAGR) of Celestial Biolabs Limited

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▼ 68%
5 years · compounded
▼ 67%
EBITDA CAGR growth
1 year
▼ 43%
3 years · compounded
▲ 82%
5 years · compounded
▼ 15%

Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 67%. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Celestial Biolabs Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹54.36 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹57.19 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Celestial Biolabs Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-322.2%••••••••••••••••
Net Profit Margin-339%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Celestial Biolabs are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Celestial Biolabs Limited

Celestial Biolabs Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology, Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Agrata Biotech Limited₹17.02 Lakh (FY 2020)••••••••••••Gerugambakkam, Tamil Nadu, India
Ficus Pharmaceuticals Private Limited₹17.01 Lakh (FY 2025)••••••••28.0%••••Patna, Bihar, India
Arcana Chemicals Limited₹17 Lakh (FY 2024)••••••••-96.0%••••Thane, Maharashtra, India
Bioartis Life Sciences Private Limited₹16.99 Lakh (FY 2020)••••••••-37.0%••••Hyderabad, Telangana, India
Super Pneumatics Pvt Ltd₹16.98 Lakh (FY 2025)••••••••5.0%••••New Delhi, Delhi, India
Celestial Biolabs Limited this company₹16.87 Lakh (FY 2023)••••••••14.0%••••Hyderabad, Telangana, India
Ninai Life Sciences Private Limited₹16.87 Lakh (FY 2025)••••••••-30.0%••••Panvel, Maharashtra, India
Med-Interplast (India) Private Limited₹16.79 Lakh (FY 2022)••••••••2.0%••••New Delhi, Delhi, India
Oyster Pharma Pvt Ltd₹16.77 Lakh (FY 2025)••••••••-68.0%••••Solan, Himachal Pradesh, India
Xena Formulations Private Limited₹16.74 Lakh (FY 2025)••••••••••••Indore, Madhya Pradesh, India
Kumra Pharma Private Limited₹16.73 Lakh (FY 2024)••••••••321.0%••••Delhi, India

Peers are the five companies nearest above and the five nearest below Celestial Biolabs by revenue in the Biotechnology industry (Biotechnology, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Celestial Biolabs Limited

Celestial Biolabs Limited is audited by M Surendra & Associates for the financial year 2022.

NameStatusAppointment DateCessation Date
M Surendra & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Celestial Biolabs Limited

Celestial Biolabs has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rakle Mathur NathDirector02 Sep 20224 Years 1 MonthsCurrent
Durga Narasimha Kumar GangadharuniDirector02 Sep 20224 Years 1 MonthsCurrent
Prabhakar KoradaDirector02 Sep 20224 Years 1 MonthsCurrent
Padma SinghDirector30 Sep 200521 Years 0 MonthsCurrent
Amit Kumar SinghManaging Director28 Sep 20179 Years 0 MonthsCurrent

Ownership and Shareholding of Celestial Biolabs Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Celestial Biolabs Limited

Open charges
₹21.1 Cr
Satisfied charges
₹8.9 Cr
Breakdown by lending institutions
State Bank of India₹21.10 Cr
Latest charge details
DateLenderAmountStatus
24 Feb 2010State Bank of India₹20 CrOpen
16 Apr 2004State Bank of India₹1.1 CrOpen
28 Dec 20073I Infotech Trusteeship Services Limited₹8.25 CrSatisfied
27 Jul 2006Technology Development Board₹49 LakhSatisfied
08 Jun 1999State Bank of India₹12.9 LakhSatisfied

Total charge records: 6 View all charges

Deals & Funding of Celestial Biolabs Limited

Celestial Biolabs Limited has 94 deals on record (93 market trades, 1 ipo); the latest was in July 2019.

Total deals
94
Market trades
93
IPO
1

Deals on record (5 of 94)

WhenDealAmountParties
Oct 2018Market trade₹29.3 LakhBuyer: NBN Fintrade Private Limited , Gigantic Enterprises
Seller: NBN Fintrade Private Limited , Gigantic Enterprises
Apr 2018Market trade₹46.8 LakhBuyer: Deepthink Ventures Private Limited , an individual
Seller: Deepthink Ventures Private Limited , an individual
Oct 2017Market trade₹1.9 CrBuyer: Shreni Shares Limited
Seller: Shreni Shares Limited , an individual
Mar 2017Market trade₹31.9 LakhBuyer: Neon Vinimay Private Limited
Seller: Neon Vinimay Private Limited
Feb 2017Market trade₹26.5 LakhBuyer: Neon Vinimay Private Limited
Seller: Neon Vinimay Private Limited
Premium access

Full deal history

All 94 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Associated Brands with Celestial Biolabs Limited

Celestial Biolabs operates two associated brands: Celestial Biolabs and Celestia. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer of clinically validated biopharmaceutical productscelestialbiolabs.com
Blockchain-based modular consensus and data networkcelestia.org

Employees and EPFO Compliance at Celestial Biolabs Limited

Celestial Biolabs Limited has a workforce of 1 employees as of Apr 05, 2024.

Employee count
1
Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Name History of Celestial Biolabs Limited

Celestial Biolabs has undergone 3 name changes throughout its history. The company was previously known as Celestial Labs Limited, Celestial Technologies Limited, and Celestial Technologies Private Limited. The current legal name is Celestial Biolabs Limited.

Company NameStatus
Celestial Biolabs LimitedCurrent
Celestial Labs LimitedPrevious
Celestial Technologies LimitedPrevious
Celestial Technologies Private LimitedPrevious

CIN History of Celestial Biolabs Limited

Celestial Biolabs has one previous CIN (Corporate Identification Number): L72200AP1997PLC028374. The current CIN is L72200TG1997PLC028374, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L72200TG1997PLC028374Current
L72200AP1997PLC028374Previous

Recent Activity on Celestial Biolabs Limited

Celestial Biolabs Limited has 17 board changes on record since 2005: 11 appointments and 6 cessations. The latest: Chidvilasa Sastri Devarakonda ceased to be Director on 22 Apr 2024.

AGM
Celestial Biolabs Limited last Annual general meeting of members was held on 23 May 2024 as per latest MCA records.
Ceased
Chidvilasa Sastri Devarakonda ceased to be Director.
Ceased
Padmanabha Rao Amarachinta ceased to be Director.
Filing
Celestial Biolabs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Appointed
Durga Narasimha Kumar Gangadharuni was appointed as Director.
Appointed
Prabhakar Korada was appointed as Director.
Appointed
Rakle Mathur Nath was appointed as Director.
Ceased
Aditya Narayan Singh ceased to be Managing Director.
Appointed
Padmanabha Rao Amarachinta was appointed as Director.
Ceased
Jeetainder Roy Gour ceased to be Director.
Appointed
Amit Kumar Singh was appointed as Managing Director.
Ceased
Sivakumar Bhattiprolu ceased to be Director.

19 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Celestial Biolabs Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Celestial Biolabs Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Celestial Biolabs Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Celestial Biolabs Limited

Celestial Biolabs has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AABCC4698Q1ZVTelanganaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Celestial Biolabs Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Celestial Biolabs Limited

Celestial Biolabs is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 November 1997 (29+ years old) and is registered under CIN L72200TG1997PLC028374. Listed on BSE: 532871.

Celestial Biolabs reported revenue of ₹16.87 Lakh for FY 2023 (up 14% YoY).

Celestial Biolabs has 5 current directors:

Celestial Biolabs reported a net loss of ₹57.19 Lakh (net margin -339%) and EBITDA of -₹54.36 Lakh (EBITDA margin -322.2%) for FY 2023, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Celestial Biolabs is -68% over three years and -67% over five years. In the latest year (FY 2023) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Celestial Biolabs is 36AABCC4698Q1ZV, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Celestial Biolabs is L72200TG1997PLC028374. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Celestial Biolabs is listed on BSE with code 532871.

Celestial Biolabs has 21 court cases on record: 10 filed by the company and 2 filed against it. 2 are pending. Most are in the high courts.

Celestial Biolabs was incorporated on 19 November 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.

Celestial Biolabs has 94 deals on record (93 market trades, 1 ipo); the latest was in July 2019.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available